Please login to the form below

Not currently logged in
Email:
Password:

UK

This page shows the latest UK news and features for those working in and with pharma, biotech and healthcare.

Finch Therapeutics bags $53m for microbiome therapies

Finch Therapeutics bags $53m for microbiome therapies

Last June, Roche’s biotech division Genentech signed a $534m deal with UK biotech Microbiotica, to access its precision metagenomics microbiome platform to analyse patient samples from clinical trials of its

Latest news

  • Early ‘no’ for GW Pharma’s epilepsy drug, but NICE vows to collaborate Early ‘no’ for GW Pharma’s epilepsy drug, but NICE vows to collaborate

    In the US, the oral liquid product costs $32, 500 for a year's worth of treatment. The company hasn't confirmed its UK list price yet, but NICE has already ... It then anticipates launches expected in France, Germany and UK by the end of the year, with

  • NICE’s long-serving chief exec Sir Andrew Dillon to step down NICE’s long-serving chief exec Sir Andrew Dillon to step down

    Cutbacks in public sector spending in the UK in recent years have seen the organisation forced to streamline its operations, while at the same time taking on responsibility for reviews of ... Mike Thompson, chief executive of the UK industry association

  • Roche’s Hemlibra scores broader NHS funding Roche’s Hemlibra scores broader NHS funding

    There are an estimated 5, 930 people registered with haemophilia A in the UK, which means Hemlibra will be available to around a third of all patients. ... prophylactic medicine that can be administered subcutaneously and maintains a sustained

  • NICE’s fast-track catapults Skyrizi into market NICE’s fast-track catapults Skyrizi into market

    The fast-track approval is great news for Boehringer and AbbVie – the latter has seen its UK revenues from Humira (adalimumab) plummet since late 2018. ... Dr Alice Butler, UK medical director, AbbVie confirmed last month that Skyrizi’s NICE

  • UK no longer measles-free as vaccination rates fall dramatically UK no longer measles-free as vaccination rates fall dramatically

    PM Boris Johnson calls for urgent action. The UK has lost its measles-free status just three years after the World Health Organization (WHO) declared that the country had eliminated the ... The falling rates of childhood vaccinations is not a problem

More from news
Approximately 315 fully matching, plus 3,210 partially matching documents found.

Latest Intelligence

  • AI is transforming pharma R&D – now it can transform pharma marketing AI is transforming pharma R&D – now it can transform pharma marketing

    Early successes. In 2018 Teva created Braltusbot, a chatbot for HCPs on their UK Braltus website. ... Kim Innes, General Manager, Teva UK and Ireland said: “The experience for a worried HCP must be seamless.

  • The fight for affordable insulin The fight for affordable insulin

    Dialogue with pharma? No thanks. As with the UK’s Cystic Fibrosis Buyers’ Club advocates, T1International doesn’t see dialogue with pharma as being worthwhile – after years of frustration and debates

  • The Cystic Fibrosis Buyers’ Club The Cystic Fibrosis Buyers’ Club

    Diarmaid McDonald is lead organiser of Just Treatment, a UK-based patient activist group which is challenging the government to take whatever steps necessary to ensure access to new medicines at ... Just Treatment is also urging the UK government to

  • Innovation and digital health comms recognised at Communiqué Awards Innovation and digital health comms recognised at Communiqué Awards

    The work was centred around an awareness campaign on meningococcal meningitis, and the need for vaccination, targeting 15-24-year olds – the second highest at-risk group in the UK.

  • Building Europe’s next breakthrough biotechs Building Europe’s next breakthrough biotechs

    life sciences campus in central Cambridge where AstraZeneca, Cancer Research UK and other leading research organisations are based. ... In addition to this, Cambridge is the UK’s fastest growing city economy.

More from intelligence
Approximately 27 fully matching, plus 411 partially matching documents found.

Latest appointments

More from appointments
Approximately 14 fully matching, plus 589 partially matching documents found.

Latest from PMHub

  • Empowered patients: shaking the foundations of healthcare

    44 203 328 1840. Address:. Blue Latitude Health (UK). 140 Aldersgate Street.

  • A uniquely English genomic medicine service

    The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. ... Dr Tom Fowler has played a core role in implementing genomic medicine in the UK.

  • Cello Health Acquire ISS

    Acquisition further strengthens technical advisory services in US. Cello Health has announced further expansion in the United States with the acquisition of New Jersey-based company Innovative Science Solutions, LLC (‘ISS  ’) on August 15.

  • Blended Intelligence

    Reminding our audiences of this, we invited them to help address a surprising UK dehydration epidemic. ... The research revealed which stakeholders, in particular, we needed to listen to in order to really make a difference to the UK dehydration epidemic.

  • Planning a pharma exhibition stand? You must read this!

    Apex is one of the UK’s leading exhibition agencies. A specialist supplier to the healthcare and pharmaceutical industries, we understand your communication goals.

More from PMHub
Approximately 33 fully matching, plus 1,028 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics